Concepedia

Nabholtz Jm

NJ

Statistics

Publications

6

Citations

265

H-Index

6

Active since

1998

Affiliations

Institute of Cancer Research(Current)

Alberta Cancer Foundation

Nabholtz Jm is an author at Institute of Cancer Research specializing in oncology, medicine, and chemotherapy.

Publications per year

1998–2019

6

Publications

6

6 months versus 12 months of adjuvant trastuzumab in early breast cancer (PHARE): final analysis of a multicentre, open-label, phase 3 randomised trial

Xavier Pivot, Gilles Romieu, Marc Debled et al. · The Lancet · 2019 · 128 citations

Medicine, Oncology, Breast Oncology +9

A longitudinal prospective study of health-related quality of life in breast cancer patients following high-dose chemotherapy with autologous blood stem cell transplantation

Barbara Conner‐Spady, C. E. Cumming, Nabholtz Jm et al. · Bone Marrow Transplantation · 2005 · 61 citations

Medicine, Oncology, Breast Oncology +15

Phase III studies of single-agent docetaxel in patients with metastatic breast cancer who have progressed despite previous chemotherapy regimens: preliminary results.

Nabholtz Jm, John Crown · PubMed · 1998 · 27 citations

Medicine, Oncology, Pharmacology +12

Docetaxel and anthracycline polychemotherapy in the treatment of breast cancer.

Nabholtz Jm, Michael Smylie, J. Mackey et al. · PubMed · 1999 · 18 citations

Medicine, Oncology, Pharmacology +13

Taxane-based three-drug combination in metastatic and adjuvant treatment of breast cancer.

Nabholtz Jm, J. Mackey, Michael Smylie et al. · PubMed · 1998 · 16 citations

Medicine, Oncology, Pharmacology +16

1–5 of 6